The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins
Open accessPublished version of a preprint
Abstract
Background: Acinetobacter baumannii is one of the most life-threatening multidrug-resistant pathogens worldwide. Currently, 50%–70% of clinical isolates of A. baumannii are extensively drug-resistant, and available antibiotic options against A. baumannii infections are limited. There is still a need to discover specific de facto bacterial antigenic proteins that could be effective vaccine candidates in human infection. With the growth of research in recent years, several candidate molecules have been identified for vaccine development. So far, no public health authorities have approved vaccines against A. baumannii . Methods: This study aimed to identify immunodominant vaccine candidate proteins that can be immunoprecipitated specifically with patients’ IgGs, relying on the hypothesis that the infected person’s IgGs can capture immunodominant bacterial proteins. Herein, the outer-membrane and secreted proteins of sensitive and drug-resistant A. baumannii were captured using IgGs obtained from patient and healthy control sera and identified by Liquid Chromatography- Tandem Mass Spectrometry (LC-MS/MS) analysis. Results: Using the subtractive proteomic approach, we determined 34 unique proteins captured only in drug-resistant A. baumannii strain via patient sera. After extensively evaluating the predicted epitope regions, solubility, transverse membrane characteristics, and structural properties, we selected several notable vaccine candidates. Conclusion: We identified vaccine candidate proteins that triggered a de facto response of the human immune system against the antibiotic-resistant A. baumannii . Precipitation of bacterial proteins via patient immunoglobulins was a novel approach to identifying the proteins that could trigger a response in the patient immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Universal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Perez-Riverol, Y., Bai, J., Bandla, C., García-Seisdedos, D., Hewapathirana, S., Kamatchinathan, S., Kundu, D. J., Prakash, A., Frericks-Zipper, A., Eisenacher, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1038 · Cited by 6,125
Manual of clinical microbiology
Drasar, B. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90074-5 · Cited by 2,594
Improved method for predicting linear B-cell epitopes.
Larsen, J., Lund, O., & Nielsen, M. (2006) · Immunome Research · doi:10.1186/1745-7580-2-2 · Cited by 1,413
Acinetobacter baumannii: An emerging opportunistic pathogen
Howard, A., O’Donoghue, M., Feeney, A., & Sleator, R. D. (2012) · Virulence · doi:10.4161/viru.19700 · Cited by 837
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
The Ecology, Biology and Pathogenesis of Acinetobacter spp.: An Overview
Doughari, H. J., Ndakidemi, P. A., Human, I. S., & Benade, S. (2011) · Microbes and Environments · doi:10.1264/jsme2.me10179 · Cited by 453
The Immune Epitope Database and Analysis Resource: From Vision to Blueprint
Peters, B., Sidney, J., Bourne, P., Bui, H.-H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R., Lund, O., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030091 · Cited by 373
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace
Roca, I., Espinal, P., Vila-Farrés, X., & Vila, J. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00148 · Cited by 363
Regulation of Acinetobacter Baumannii Biofilm Formation
Gaddy, J. A., & Actis, L. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.5 · Cited by 321
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
The Global Problem of Antibiotic Resistance
Gootz, T. D. (2010) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v30.i1.60 · Cited by 238
PROSO II – a new method for protein solubility prediction
Smialowski, P., Doose, G., Torkler, P., Kaufmann, S., & Frishman, D. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08603.x · Cited by 220
Inactivation of Phospholipase D Diminishes Acinetobacter baumannii Pathogenesis
Jacobs, A. C., Hood, I., Boyd, K. L., Olson, P. D., Morrison, J. M., Carson, S., Sayood, K., Iwen, P. C., Skaar, E. P., & Dunman, P. M. (2010) · Infection and Immunity · doi:10.1128/iai.00889-09 · Cited by 214
Luo, G., Lin, L., Ibrahim, A. S., Baquir, B., Pantapalangkoor, P., Bonomo, R. A., Doi, Y., Adams, M. D., Russo, T. A., & Spellberg, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029446 · Cited by 195
A sequence-profile-based HMM for predicting and discriminating β barrel membrane proteins
Martelli, P. L., Fariselli, P., Krogh, A., & Casadio, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s46 · Cited by 193
Multidrug-ResistantAcinetobacterspp.: Increasingly Problematic Nosocomial Pathogens
Lee, K., Yong, D., Jeong, S. H., & Chong, Y. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.6.879 · Cited by 178
Kim, S. W., Choi, C. H., Moon, D. C., Jin, J. S., Lee, J. H., Shin, J.-H., Kim, J. M., Lee, Y. C., Seol, S. Y., Cho, D. T., et al. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01820.x · Cited by 163
Combination therapy for carbapenem-resistant Gram-negative bacteria
Zavascki, A. P., Bulitta, J. B., & Landersdorfer, C. B. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.845523 · Cited by 144
Kaffarnik, F., Jones, A. M. E., Rathjen, J. P., & Peck, S. C. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800043-mcp200 · Cited by 138
Fattahian, Y., Rasooli, I., Gargari, S. L. M., Rahbar, M. R., Astaneh, S. D. A., & Amani, J. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.09.004 · Cited by 135
Hassan, A., Naz, A., Obaid, A., Paracha, R. Z., Naz, K., Awan, F. M., Muhmmad, S., Janjua, H. A., Ahmad, J., & Ali, A. (2016) · BMC Genomics · doi:10.1186/s12864-016-2951-4 · Cited by 114
Bentancor, L. V., O'Malley, J. M., Guzel, C. B., Pier, G. B., & Maira‐Litrán, T. (2011) · Infection and Immunity · doi:10.1128/iai.05653-11 · Cited by 102
Exploiting the peptidoglycan-binding motif, LysM, for medical and industrial applications
Visweswaran, G. R. R., Leenhouts, K. J., van Roosmalen, M. L., Kok, J., & Buist, G. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5633-7 · Cited by 94
Singh, R., Capalash, N., & Sharma, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12789-3 · Cited by 93
GlycoPP: A Webserver for Prediction of N- and O-Glycosites in Prokaryotic Protein Sequences
Chauhan, J. S., Bhat, A. H., Raghava, G. P. S., & Rao, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040155 · Cited by 90
Identification of novel vaccine candidates againstAcinetobacter baumanniiusing reverse vaccinology
Chiang, M., Sung, W., Lien, S., Chen, Y.-Z., Lo, A. F.-Y., Huang, J.-H., Kuo, S., & Chong, P. C.-S. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1010910 · Cited by 89
Identification of Novel Vaccine Candidates against Multidrug-Resistant Acinetobacter baumannii
Moriel, D. G., Beatson, S. A., Wurpel, D. J., Lipman, J., Nimmo, G. R., Paterson, D. L., & Schembri, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077631 · Cited by 86
Inclusion of dyad-repeat pattern improves topology prediction of transmembrane β-barrel proteins
Hayat, S., Peters, C., Shu, N., Tsirigos, K. D., & Elofsson, A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw025 · Cited by 85
MayaChemTools: An Open Source Package for Computational Drug Discovery
Sud, M. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00505 · Cited by 84
Ni, Z., Chen, Y., Ong, E., & He, Y. O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020458 · Cited by 66
Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
Gellings, P. S., Wilkins, A. A., & Morici, L. A. (2020) · Pathogens · doi:10.3390/pathogens9121066 · Cited by 62
Mendez, J. A., Soares, N. C., Mateos, J., Gayoso, C., Rumbo, C., Aranda, J., Tomás, M., & Bou, G. (2012) · Journal of Proteome Research · doi:10.1021/pr300496c · Cited by 56
Yun, S., Choi, C.-W., Park, S.-H., Lee, J. C., Leem, S., Choi, J., Kim, S., & Kim, S. I. (2008) · The Journal of Microbiology · doi:10.1007/s12275-008-0202-3 · Cited by 54
Taneja, N., Singh, G., Singh, M., & Sharma, M. (2011) · PubMed · Cited by 53
New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method
Fereshteh, S., Abdoli, S., Shahcheraghi, F., Ajdary, S., Nazari, M., & Badmasti, F. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104114 · Cited by 51
Lei, L., Yang, F., Zou, J., Jing, H., Zhang, J., Zhang, J., Xu, W., Zou, Q., Zhang, J., Zhang, J., et al. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04994-2 · Cited by 47
Bonin, R. F., Chapeaurouge, A., Perales, J., da Silva, J. G., Nascimento, H. J., Carvalho-Assef, A. P. D., & Senna, J. P. M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300133 · Cited by 44
Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years
Tan, Y. C., & Lahiri, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900509 · Cited by 41
Bai, Y., Liu, B., Wang, T., Cai, Y., Liang, B., Wang, R., Liu, Y.-N., & Wang, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04089-14 · Cited by 30
López, M. C., Blasco, L., Gato, E., Pérez, A., Fernández-García, L., Martı́nez-Martı́nez, L., Fernández-Cuenca, F., Rodríguez‐Baño, J., Pascual, Á., Bou, G., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00143 · Cited by 30
Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii
Pachón, J., & McConnell, M. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.064 · Cited by 28
Verma, P., & Tiwari, V. (2018) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-018-0846-5 · Cited by 28
Scribano, D., Marzano, V., Mortera, S. L., Sarshar, M., Vernocchi, P., Zagaglia, C., Putignani, L., Palamara, A. T., & Ambrosi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143451 · Cited by 25
Fractionation by Ultracentrifugation of Gram Negative Cytoplasmic and Membrane Proteins
Sandrini, S. M., Haigh, R. C., & Freestone, P. P. E. (2014) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1287 · Cited by 21
Analysis of the Extracellular Proteome of Colistin-Resistant Korean Acinetobacter baumannii Strains
Lee, S.-Y., Yun, S. H., Lee, H., Yi, Y.-S., Park, E. C., Kim, W., Kim, H., Lee, J. C., Kim, G., & Kim, S. I. (2020) · ACS Omega · doi:10.1021/acsomega.9b03723 · Cited by 21
Chaudhuri, S., Rasooli, I., Oskouei, R. H., Pishgahi, M., Jahangir, A., Andisi, V. F., & Schryvers, A. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933445 · Cited by 21
Fernández-Cuenca, F., Tomás, M., Caballero-Moyano, F. J., Bou, G., Pascual, Á., Vilanova, A., Benítez, A. B., Montiel, N., Calleja, A. I. L., Guerra, L. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx464 · Cited by 18
West, R., Whitmon, J., Williamson, Y. M., Moura, H., Nelson, M., Melnick, N., Tondella, M. L., Schieltz, D. M., Rees, J. C., Woolfitt, A. R., et al. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2011.12.034 · Cited by 16
Gu, Y., Zhang, W., Lei, J., Zhang, L., Hou, X., Tao, J., Wang, H., Deng, M., Zhou, M., Weng, R., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.983963 · Cited by 15
Martín-Galiano, A. J., Díez‐Fuertes, F., McConnell, M. J., & López, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732693 · Cited by 9
Research works printed but not linked: 1
- Schreckenberger, 2002, Acinetobacter, achromobacter, chryseobacterium, moraxella, and other nonfermentative gram-negative rods
Metadata
- Authors
- Acar, M. B., Ayaz-Güner, Ş., Güner, H., Dinç, G., Ulu Kılıç, A., Doğanay, M., & Özcan, S.
- Affiliations
- Erciyes University (TR)
- Abdullah Gül University (TR)
- Lokman Hekim Üniversitesi (TR)
- Corresponding author
- Özcan, Servet
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-11-10
- Volume
- 13
- Pages
- 1001633-1001633
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9687788
- OpenAlex
- W4308878067
- Cited by
- 8
- References
- 52
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2022: 1
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IYTE GCRIS Database (Izmir Institute of Technology) (submittedVersion, other-oa)
- Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (114S571)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- Acinetobacter baumannii, vaccine candidate proteins, immunodominant antigens, subtractive proteomics, outer membrane proteins, secreted proteins, multidrug resistance, drug-resistant bacteria, epitope prediction, bacterial antigens
- MeSH terms
- Anti-Bacterial Agents, Bacterial Proteins, Chromatography, Liquid, Humans, Proteomics, Acinetobacter baumannii, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.